![]() |
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
Research Interests We are studying the mechanisms by which programmed cell death (apoptosis)
is regulated during T cell development and immune responses. Our previous
work have demonstrated that activation of immature T cells and T cell
hybridomas leads to apoptosis. We have also shown that proto-oncogene
c-myc plays a pivotal role in this process. Our recent studies have demonstrated
that c-myc is required for activation-induced expression of Fas ligand
(FasL). Although Fas is also induced by activation, its expression does
not require c-myc; instead it requires translocation of protein kinase
C (PKC). Since the expression and subsequent interaction of Fas and FasL
is absolutely required for activation-induced T cell apoptosis, the determination
of the molecular mechanisms of c-myc-mediated FasL expression and PKC-mediated
Fas expression will lead to fundamental understanding of the regulation
of the immune system. Selected Publications Top Contact Information Top
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||